Proton Pump Inhibitor Use, Hip Fracture and Change in Bone Density In Postmenopausal Women Results from the Women’s Health Initiative

BACKGROUND: Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. The objective was to examine the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]) METHODS: This prospective analysis included 161,806 postm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arch Intern Med
Main Authors: Gray, Shelly L., LaCroix, Andrea Z., Larson, Joseph, Robbins, John, Cauley, Jane A., Manson, JoAnn E., Chen, Zhao
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240017/
https://ncbi.nlm.nih.gov/pubmed/20458083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2010.94
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados